DR. JONATHAN MICHAEL GREER M.D. NPI 1003816281

NPI Details

DR. Jonathan Michael Greer, M.D. is a rheumatology internal medicine in Boynton Beach, FL with 43 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. DR. Jonathan Michael Greer, M.D. NPI is 1003816281. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE
Graduation Year:1983

The provider's business location address is:

6056 BOYNTON BEACH BLVD STE 145
BOYNTON BEACH, FL
ZIP 33437-500
Phone: (561) 439-1800
Fax: (561) 439-4874

The NPI 1003816281 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, tocilizumab, 1 mg (HCPCS:J3262)
• Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, romosozumab-aqqg, 1 mg (HCPCS:J3111)
• Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
• Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
• Injection, infliximab, excludes biosimilar, 10 mg (HCPCS:J1745)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, rituximab, 10 mg (HCPCS:J9312)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg (HCPCS:J0702)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Complete ultrasound scan of joint (HCPCS:76881)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• X-ray of knee, 3 views (HCPCS:73562)
• Injection, methylprednisolone sodium succinate, up to 40 mg (HCPCS:J2920)
• Injection of trigger points, 1-2 muscles (HCPCS:20552)
• X-ray of lower and sacral spine, 2-3 views (HCPCS:72100)
• X-ray of pelvis, 1-2 views (HCPCS:72170)
• Aspiration and/or injection of fluid from small joint (HCPCS:20600)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• X-ray of shoulder, minimum of 2 views (HCPCS:73030)
• X-ray of hand, minimum of 3 views (HCPCS:73130)
• Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
• X-ray of middle spine, 2 views (HCPCS:72070)
• Hyaluronan or derivative, gel-one, for intra-articular injection, per dose (HCPCS:J7326)
• Injection into tendon at attachment to bone or muscle (HCPCS:20551)
• X-ray of upper spine, 4-5 views (HCPCS:72050)

The enumeration date for this NPI number is 7/28/2005 and was last updated on 1/31/2019.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: